Journal
CURRENT DRUG TARGETS
Volume 22, Issue 12, Pages 1334-1345Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389450122666210120084406
Keywords
Antimicrobial resistance; antibiotic adjuvants; beta-Lactamase inhibitors; efflux pump inhibitors; membrane permeabi-lizers; adjuvant targets
Categories
Funding
- University Grant Commission (New Delhi)
- UGC-Special Assistance Programme (SAP)
- DST-FIST
Ask authors/readers for more resources
The emergence and prevalence of infections caused by multi-drug resistant bacteria highlight the urgent need for novel therapeutic strategies. Existing strategies seem to be less effective, and antibiotic adjuvants are seen as a promising approach to overcome bacterial resistance.
The escalating emergence and prevalence of infections caused by multi-drug resistant (MDR) pathogenic bacteria accentuate the crucial need to develop novel and effectual therapeutic strategies to control this threat. The recent past surprisingly indicates a staggering decline in effective strategies against MDR. Different approaches have been employed to minimize the effect of resistance, but the question still lingers over the astounding number of drugs already tried and tested. Furthermore, the detection of new drug targets and the action of new antibacterial agents against already existing drug targets also complicate the condition. Antibiotic adjuvants are considered as one such promising approach for overcoming bacterial resistance. Adjuvants can potentiate the action of generally adopted antibacterial drugs against MDR bacterial pathogens either by minimizing the impact and emergence of resistance or improving the action of antibacterial drugs. This review provides an overview of the mechanism of antibiotic resistance, the main types of adjuvants and their mode of action, achievements and progression.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available